{
    "clinical_study": {
        "@rank": "119277", 
        "arm_group": [
            {
                "arm_group_label": "Placebo solution", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A 100 ml placebo solution  will be administered through an esophageal probe. 100 ml will be administered as an infusion with a rate of 7ml/min. Healthy volunteers will be treated with placebo in one out of three visit days."
            }, 
            {
                "arm_group_label": "PPC-5650", 
                "arm_group_type": "Active Comparator", 
                "description": "PPC\u20105650 is a \"asic-sensing ion channel\"-1a antagonist that can block the acid-sensing ion channels, leading to a reduction in the pain signal under up-regulated conditions. A dose of 2.5 mg PPC-5650 in a 100 ml solution will be administered through an esophageal probe to assess local effects. 100 ml will be administered as an infusion with a rate of 7ml/min. Healthy volunteers will be treated with PPC-5650 in one out of three visit days."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this trial is to evaluate the effect of a single PPC\u20105650 dose in a human\n      pain model including multimodal (mechanical, thermal, electrical, chemical) stimulations of\n      the esophagus."
        }, 
        "brief_title": "A Study of Local Effect and Safety of a Single PPC-5650 Dose on Reflux Pain During Pain Stimulation in the Esophagus", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Gastroesophageal Reflux", 
            "Gastroesophageal Reflux Disease"
        ], 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent before any study specific procedures\n\n          -  Able to read and understand Danish.\n\n          -  Healthy i.e. no history of chronic or recurrent pain rewarding diseases\n\n          -  Able to co-operate and tolerate the experimental procedures (as assessed     in the\n             training visit)\n\n          -  No over the counter medication 24h before the three visits\n\n          -  No medications in the study period\n\n          -  BMI 18.5-35.0\n\n          -  Caucasian\n\n          -  No symptoms of Gastroesophageal reflux disease\n\n          -  All men must use a safe method of contraception during the study period\n\n        Exclusion Criteria:\n\n          -  Any clinically relevant abnormal values from the laboratory tests on hematology,\n             clinical chemistry, and/or urine analyses, as judged by the investigator.\n\n          -  Participation in any other clinical trial within three months prior to the training\n             day.\n\n          -  Alcohol or drug abuse.\n\n          -  Mental illnesses\n\n          -  Allergic to the active ingredient in the investigational medicinal product"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01818570", 
            "org_study_id": "AROS-002"
        }, 
        "intervention": [
            {
                "arm_group_label": "PPC-5650", 
                "description": "A dose of 2.5 mg PPC-5650 in a 100 ml solution will be administered to the esophagus with an infusion rate of 7ml/min in one out of three visit days.", 
                "intervention_name": "PPC-5650", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo solution", 
                "description": "A 100 ml placebo solution will be administered to the esophagus with an infusion rate of 7ml/min in one out of three visit days.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Gastroesophageal Reflux", 
        "lastchanged_date": "May 13, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aalborg", 
                    "country": "Denmark", 
                    "state": "Jutland", 
                    "zip": "9000"
                }, 
                "name": "Mech-Sense, Department of Medical Gastroenterology, Aalborg University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Single-center, Randomized, Double-blind, Cross-over Trial in Healthy Volunteers Investigating the Local Efficacy and Safety of a Single Intra-luminal Administration of PPC-5650 on Reflux Pain and Hyperalgesia During Multimodal Stimulation of the Esophagus", 
        "overall_official": {
            "affiliation": "Mech-Sense, Department of Medical Gastroenterology, Aalborg Hospital", 
            "last_name": "Asbj\u00f8rn M Drewes, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: Danish Health and Medicines Authority"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Changes in pain scores recorded after multimodal pain stimulations (mechanical, thermal, electrical, and chemical)", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01818570"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aalborg Universityhospital", 
            "investigator_full_name": "Asbj\u00f8rn Mohr Drewes", 
            "investigator_title": "Professor, MD, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Number of observed adverse effects (safety profile) and changes in size of referred pain area", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "source": "Aalborg Universityhospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asbj\u00f8rn Mohr Drewes", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}